Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2028-06-16 (572 days left) |
| Published | 2026-08-31 |
| Sectors | Health & life sciences, Research & innovation |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-27-053. CFDA: 93.279
The buyer, the value, the full description and the link to the official notice are available with a free account.